Drug intelligence / Profile preview

Daxxin Psoriasis

Development stage
Unknown
Lead developer
Allderma
Modality
Small Molecules
Administration
Topical
01

Overview

Daxxin Psoriasis is a topical shampoo treatment developed and marketed by the Swedish pharmaceutical company Allderma. It is specifically formulated to alleviate symptoms associated with scalp psoriasis, seborrheic dermatitis, and persistent dandruff, such as itching, redness, and scaling. Classified as a CE-marked medical device, the product contains piroctone olamine as its primary active ingredient, which provides antifungal and antimicrobial properties. The formulation is designed to be gentle, excluding sulfates, phthalates, parabens, and cortisone, and includes guar gum for moisturizing. It is intended for daily use as a replacement for regular shampoo but is not a substitute for prescribed medical treatments like biologics or corticosteroids.

Brand names
Daxxin PsoriasisDaxxin
Other names
Daxxin Psoriasis Shampoo

Beyond the preview

Go deeper on Daxxin Psoriasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daxxin Psoriasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call